Filing Details

Accession Number:
0001209191-22-005116
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-26 19:29:59
Reporting Period:
2022-01-24
Accepted Time:
2022-01-26 19:29:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1142750 Amn Healthcare Services Inc AMN Services-Help Supply Services (7363) 061500476
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1158584 R Susan Salka 8840 Cypress Waters Blvd., Suite 300
Coppell TX 75019
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-01-24 1,200 $92.49 18,644 No 4 S Direct
Common Stock Disposition 2022-01-24 3,200 $93.19 15,444 No 4 S Direct
Common Stock Disposition 2022-01-24 4,585 $94.71 10,859 No 4 S Direct
Common Stock Disposition 2022-01-24 3,045 $95.31 7,814 No 4 S Direct
Common Stock Disposition 2022-01-24 3,373 $96.15 4,441 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sale of 1,200 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported in this row represents a weighted average price of $92.494 per share. These shares were sold in multiple transactions at prices ranging from $91.63 to $92.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  3. The sale of 3,200 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  4. The price reported in this row represents a weighted average price of $93.1878 per share. These shares were sold in multiple transactions at prices ranging from $92.74 to $93.635, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  5. The sale of 4,585 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  6. The price reported in this row represents a weighted average price of $94.71 per share. These shares were sold in multiple transactions at prices ranging from $93.99 to $94.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  7. The sale of 3,045 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  8. The price reported in this row represents a weighted average price of $95.3066 per share. These shares were sold in multiple transactions at prices ranging from $95.00 to $95.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  9. The sale of 3,373 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  10. The price reported in this row represents a weighted average price of $96.1538 per share. These shares were sold in multiple transactions at prices ranging from $96.02 to $96.235, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  11. The number of shares reflected in this column does not include 101,243 vested Restricted Stock Units that the Reporting Person elected to defer at the time of grant until her separation from service with the Company.